Argyria attributed to silvadene application in a patient with dystrophic epidermolysis bullosa.
Argyria is most commonly reported in association with prolonged ingestion of silver-containing medicaments. This case illustrates the rather unique case of development of argyria following application of silver sulfadiazine in a patient with epidermolysis bullosa.